Alperen Taş | Cardiology | Best Researcher Award

Dr. Alperen Taş | Cardiology | Best Researcher Award

Ahi Evran University | Turkey

Dr. Alperen Taş is an emerging cardiology researcher whose work centers on acute heart failure, coronary syndromes, inflammatory biomarkers, prognostic scoring systems, and no-reflow phenomena. He focuses on developing and validating clinical biomarkers and risk-prediction models that enhance early diagnosis, guide clinical decisions, and improve mortality prediction in high-risk cardiac patients. His peer-reviewed contributions span key diagnostic tools, including the Scottish Inflammatory Prognostic Score, prognostic nutritional index, QT interval–GRACE score integration, intracoronary ECG, HALP score, Osaka Prognostic Score, and novel biomarkers such as PDGF-BB, chemerin, and derived NLR. His collaborative studies explore infective endocarditis, myocardial infarction, coronary no-reflow, heart failure progression, echocardiographic functional assessment, and medication-related cardiovascular effects. He has shared his findings at national cardiology congresses, advancing scientific dialogue on inflammatory markers and cardiovascular prognostication. With 12 publications, 24 citations, and an h-index of 2, Dr. Alperen Taş demonstrates solid developing research impact, strong collaboration, and a promising trajectory in preventive cardiology and biomarker-based risk stratification.

Profile: Scopus

Featured Publications

Taş, A., Tunca, Ç., Tanık, V. O., & Özlek, B. (2025). The Scottish inflammatory prognostic score: A novel biomarker for predicting in-hospital mortality in acute heart failure with reduced ejection fraction. Heart & Lung, 74, 291–299.

Mehmet Arif İçer | Cardiology | Best Researcher Award

Assist. Prof. Dr. Mehmet Arif İçer | Cardiology | Best Researcher Award

Assist. Prof. Dr. Mehmet Arif İçer, Amasya University, Turkey

Assist. Prof. Dr. Mehmet Arif İçer is a dedicated academic at the Department of Nutrition and Dietetics, Amasya University, Turkey. With a PhD from Gazi University 🎓, he has authored over 28 impactful research articles in top journals, achieving 980+ citations and an h-index of 11. His work focuses on clinical nutrition, dietary biomarkers, and metabolic health. He was named among Stanford’s Top 2% Scientists in 2024. He also serves as Head of Department and Vice Dean at Amasya University, reflecting his academic leadership. He is passionate about evidence-based nutrition and public health

Publication Profile

Google Scholar

🎓 Educational Background

Assist. Prof. Dr. Mehmet Arif İçer pursued his academic journey in Nutrition and Dietetics with distinction. He earned his PhD (2018–2022) and MSc (2016–2018) from Gazi University in Ankara, Turkey . He completed his BSc at Erciyes University, Kayseri (2009–2014), where he laid the foundation for his expertise in clinical nutrition and dietetics . Enhancing his global perspective, he participated in the Erasmus program at Semmelweis University, Budapest , during 2014. His strong academic background reflects a commitment to excellence and innovation in nutritional science and public health education

Professional Experience

Dr. Mehmet Arif İçer began his academic career as a Research Assistant at Amasya University (2014–2015) 🏫, later continuing at Gazi University from 2015 to 2022 🧪. In 2022, he returned to Amasya University as an Assistant Professor 👨‍🔬. His leadership capabilities led to appointments as the Head of the Department of Nutrition and Dietetics and Vice Dean of the Faculty of Health Sciences in 2023. Dr. İçer’s career reflects a strong dedication to research, academic development, and administrative excellence within the fields of nutrition and public health sciences

🔬 Research Focus

Dr. Mehmet Arif İçer’s research primarily explores the intersection of clinical nutrition, biochemistry, and chronic disease prevention. His studies focus on biomarkers like fetuin-A and osteopontin in metabolic and cardiovascular disorders . He also investigates orthorexia nervosa, kidney stones, and gut-brain axis interactions, particularly through the roles of dietary lipids, microbiota, and lactic acid bacteria 🧬🥦. His multidisciplinary approach bridges nutritional genomics, dietary behavior, and public health 🩺📊. With a strong emphasis on evidence-based dietary strategies, Dr. İçer contributes to advancing preventive health through innovative nutrition science and functional food research

Publication Top Notes

📘 The multiple functions and mechanisms of osteopontin – 653 citations 📈 (2018) 🧬
📘 Effects of fetuin-A with diverse functions and multiple mechanisms on human health – 62 citations 📊 (2021) 🧠
📘 The roles of dietary lipids and lipidomics in gut-brain axis in type 2 diabetes mellitus – 52 citations 🔬 (2023) 🥑🧠
📘 Effects of vitamin E on neurodegenerative diseases: An update – 42 citations 🧠 (2021) 🍊
📘 The impacts of acidophilic lactic acid bacteria on food and human health – 39 citations 🧪 (2023) 🥛
📘 Urine osteopontin levels in nephrolithiasis diagnosis – 28 citations 🧫 (2018) 🧂
📘 Effects of nutritional status on serum fetuin-A level – 25 citations 🧍‍♂️ (2020) 🧪
📘 GABA by lactic acid bacteria & human health – 17 citations 🧠 (2024) 🥬
📘 Pharmacological effects of licorice on human health – 16 citations 🌿 (2017) ⚕️
📘 Healthy food/activity choices & body weight in preschool children – 13 citations 🧒 (2017) 🥗
📘 Effects of red pepper, ginger, turmeric on energy metabolism – 11 citations 🌶️ (2021) 🔥
📘 Dietary intake & kidney stone formation risk – 9 citations 🥤 (2019) 💎
📘 PRAL level in nephrolithiasis patients & nutritional status – 5 citations 🧂 (2018) 🧪
📘 Coffee’s cardiometabolic potential & health relationships – 4 citations ☕ (2024) ❤️

HASAN SARI | Cardiology | Best Researcher Award

Dr. HASAN SARI | Cardiology | Best Researcher Award

Dr. HASAN SARI, Mut State Hospital, Turkey

Dr. Hasan Sarı (b. 01.12.1991, Manavgat/Antalya) is a specialist in Cardiology. With several published works in leading journals, Dr. Sarı has contributed extensively to the fields of cardiac tumors, syncope, and aortic aneurysms. Notable publications include studies on malignant fibrous histiocytoma, right atrial thrombosis, and coronary ectasia. He has also presented at international conferences, including the ACC Middle East & Eastern Mediterranean 2023 in Athens. Dr. Sarı completed an observership at the University of Minnesota Medical Center in 2023. He is actively engaged in advancing cardiology research. 📚💉❤️📈

 

Publication Profile

Orcid

Research Focus

Dr. Hasan Sarı’s research primarily focuses on cardiology with a special interest in coronary artery diseases, cardiac arrhythmias, vascular pathology, and predictive models for cardiovascular conditions. His work includes evaluating the relationship between coronary ectasia and trimethylamine N-oxide, as well as exploring CHA2DS2-VASc scores and left ventricular apical thrombosis in heart failure patients. His research contributes to advancing cardiac diagnostics, understanding heart failure, and identifying biomarkers for cardiovascular health. Dr. Sarı’s publications are crucial for clinical practice and prevention strategies in cardiology. 🫀🔬💉📊

 

Publication Top Notes 📚

  • “The Evaluation of the Relationship Between Coronary Ectasia and Trimethylamine N‐Oxide”International Journal of Clinical Practice (2024) 📅📝
  • “Kalp Yetmezlikli Hastalarda CHA2DS2-VASc Skoru ve Sol Ventrikül Apikal Trombozu İlişkisi”Online Türk Sağlık Bilimleri Dergisi (2022) 📅📝